Page 13 - தற்குறிப்பு ஆரம்ப கற்றல் ப்ரோக்ர்யாம்ஸ் ஔட்‌டோர்ஸ் தி லிவர்மோர் பொது நூலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தற்குறிப்பு ஆரம்ப கற்றல் ப்ரோக்ர்யாம்ஸ் ஔட்‌டோர்ஸ் தி லிவர்மோர் பொது நூலகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தற்குறிப்பு ஆரம்ப கற்றல் ப்ரோக்ர்யாம்ஸ் ஔட்‌டோர்ஸ் தி லிவர்மோர் பொது நூலகம் Today - Breaking & Trending Today

Forge Biologics Expands Gene Therapy Leadership Team with Appointment of John Maslowski as Chief Commercial Officer


Published: Jun 03, 2021
 
 
COLUMBUS, Ohio (BUSINESS WIRE) Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced today the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy manufacturing and development experience to Forge as the Company has expanded its cGMP AAV manufacturing capabilities, including process and analytical development. As CCO, Mr. Maslowski will lead the Marketing, Sales, and Client Development departments to support our partners and clients on their path towards commercializing gene therapies.
John Maslowski, Chief Commercial Officer (Photo: Business Wire)
“We are excited to have John join the leadership team at such an important inflection point in the growth of Forge,” said Timothy J. Miller, Ph.D., CEO, President and Co-Founder of Forge Biologics. “John is a seasoned biotech executive, bringi ....

United States , Villanova University , Ursinus College , Timothyj Miller , John Maslowski , Wyeth Pharmaceuticals , Client Development , Teva Pharmaceuticals , Merck Co Inc , Castle Creek Biosciences Inc , Fibrocell Science Inc , Scientific Affairs , Alliance For Regenerative Medicine , Chief Commercial , Chief Commercial Officer , Business Wire , Chief Executive Officer , Castle Creek Biosciences , Fibrocell Science , Senior Vice President , Vice President , Regenerative Medicine , Life Science Cares Philadelphia , Falcon Therapeutics , Forge Chief Commercial , Jefferies Virtual Healthcare ,

Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of DirectorsDistinguished biopharma executive brings over 20 years of leadership in life sciences


®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet ....

United States , Julie Seidel , Abilify Mycite , Annexon Biosciences , Laurence Reid , Chris Railey , Abilify Maintena , American Psychiatric Association , Stern Investor Relations Inc , Leadership Council , Sphinx Organization , Sozosei Foundation , Department Of Psychiatry , Case Western Reserve University School Of Medicine , University Of South Carolina , National Medical Association , Harvard College , Otsuka Pharmaceutical Development Commercialization Inc , Tufts University School Of Medicine , Behavioral Sciences , Otsuka Pharmaceutical Development , Board Chair Emeritus , Chief Executive , Case Western Reserve University School , Tufts University School , Distinguished Fellow ,

BioSpace Movers & Shakers, June 4


Published: Jun 03, 2021
By Alex Keown
180 Life Sciences Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Officer. Her most recent role was at Columbia University as Managing Director of NY Life Science Venture Fund. ....

Wills Eye Hospital , United States , M Karen Newell Rogers , Myers Squibb , Denise Strauss , Marc Semigran , Davidc Hanley , Eric Castaldi , Jen Hong , Meagher Flom , Marc Massiot , Newell Rogers , Robin Knifsend , Theodore Reiss , Jeff Cruikshank , Evelo Biosciences , Judith Robertson , Alexander Ferdon , Mike Nohaile , Nuvation Bio , Adam Drapczuk , Mark Plinio , Julia Haller , Antoni Ribas , Anne Walker , Ann Lee ,